M10.419
Other secondary gout, unspecified shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Other secondary gout, unspecified shoulder (ICD-10 Code M10.419), is a condition where gout affects the shoulder joint due to underlying causes other than primary gout. Gout is a form of inflammatory arthritis caused by the accumulation of uric acid crystals in the joints, leading to pain, swelling, and inflammation. When gout occurs secondary to another medical condition or due to external factors, it is classified as secondary gout. Specifically, this diagnosis pertains to gout that affects the shoulder, which is less common compared to other joints like the big toe or ankles, and does not have a specified secondary cause identified.
Causes & Symptoms
Clinical Causes: Chronic kidney disease leading to reduced uric acid clearance Use of medications such as diuretics, aspirin, or immunosuppressants that increase uric acid levels Metabolic syndrome or other systemic conditions affecting uric acid metabolism Excessive alcohol intake High-purine diet contributions Certain genetic predispositions
Key Symptoms: Severe pain in the shoulder, often sudden and intense Swelling around the shoulder joint Redness and warmth over the affected area Limited shoulder mobility due to pain and swelling Tenderness upon touch Possible presence of tophi (urate crystal deposits) in nearby tissues Flare-ups may recur periodically
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically based on clinical evaluation, patient history, and laboratory tests. The healthcare provider may perform the following assessments: - Physical examination to observe signs of inflammation and joint swelling - Blood tests measuring serum uric acid levels - Joint fluid analysis via needle aspiration to identify uric acid crystals - Imaging studies such as X-rays, ultrasound, or dual-energy CT scans to detect joint damage or crystal deposits Since the condition is classified as 'unspecified shoulder,' the exact secondary cause may not be clear from initial assessments, prompting further investigation if necessary.
Treatment Protocols: Management of secondary gout in the shoulder includes a combination of approaches aimed at reducing pain, controlling inflammation, and addressing underlying causes: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to alleviate pain and inflammation - Colchicine for acute attacks - Corticosteroid injections into the shoulder joint to reduce severe inflammation - Lifestyle modifications such as dietary changes to lower purine intake and reducing alcohol consumption - Medications to lower uric acid levels, including allopurinol or febuxostat, may be prescribed for long-term management - Managing secondary causes like kidney disease or medication adjustments - Rest and ice application to reduce swelling during flare-ups It’s important for individuals with secondary gout to work closely with healthcare professionals to manage both gout symptoms and the underlying conditions contributing to their elevated uric acid levels.
Clinical Advice & FAQs
Billing Guidance
Is M10.419 a billable ICD-10 code?
Yes, M10.419 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.419?
Clinical documentation must specify the nature of Other secondary gout, unspecified shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference